Some Drugs Less Harsh Than Others for IBS, Cedars-Sinai Medical Center Study Says
Published: Mar 27, 2012
ScienceDaily (Mar. 26, 2012) — Cedars-Sinai researchers have determined that two prevalent drug therapies -- rifaximin and lubiprostone -- offer some of the best options for treating irritable bowel syndrome, a widespread disorder that affects up to one in five Americans. The findings, based on an analysis of more than two dozen large-scale clinical trials, are contained in a peer-reviewed study published online by The American Journal of Medicine and set to appear in the publication's April print edition.